Cetuximab-Related Skin Toxicity as a Prognostic Marker in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Analysis of the EXTREME Regimen
Objective: Cetuximab-induced skin toxicity has been proposed as a predictive biomarker of treatment efficacy in cetuximab-based regimens. However, its prognostic significance in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with the EXTREME regimen remains limited. This study investi...